Rigora
Clinical trial monitoring software
An AI-native clinical monitoring layer that continuously reconciles site source documents against the eCRF, flags discrepancies, and drafts queries and monitoring visit reports (MVRs) for CRAs to review, edit and sign.
- Continuous source data verification and source data review between site visits
- Automatic reconciliation of source documents against the eCRF with discrepancy flagging
- Drafted queries and monitoring visit reports that a named reviewer must edit and approve
- Read-only architecture that never writes to EDC or EHR systems
- Per-value provenance and an append-only, database-enforced audit trail
- Tenant isolation via database row-level security
- Transparent AI output showing structured inputs alongside drafts with explicit [VERIFY: ...] uncertainty tags
- Tiered deployment starting with zero integration, with optional central-lab and FHIR feeds added later
- White-label deployment under a CRO's own brand with multi-sponsor isolation
Built for
Mid-size and specialty contract research organizations running monitored studies, plus biotech and pharma sponsors, across both drug trials and Class II/III device studies, with stated focus areas in oncology, neurology, immunology and rare disease.